Advances in technology are a key driver in any ophthalmic practice, making procedures more effective – and, in some cases, safer. First introduced in the eighties with reports of limited success, Laser Floater Removal (LFR) has undergone a renaissance with the recent innovation of technologies such as titratable axis illumination and coaxial visualization. Today, ophthalmologists can offer their symptomatic floater patients treatment with LFR with greater safety and efficacy than ever before.

The LFT Blog addresses the evolving role of LFT in clinical practice. Curated by Paul I. Singh, MD, who has performed more than 3,000 LFT procedures, it addresses a number of topics relating to the treatment of symptomatic floater patients. Dr. Singh is in private practice at The Eye Centers of Racine & Kenosha in Wisconsin, USA. He was the first ophthalmologist in Wisconsin and Illinois to implant the iStent glaucoma drainage device, and, more recently has helped to pioneer the development of new lenses and laser technologies for use in LFT.

5 April 2018When is a condition “Bad Enough to Treat?”

Author: Dr. Paul I. Singh

When is a condition “Bad Enough to Treat?”   In medicine, our decision to treat or not to treat a condition has been based on the risk-benefit ratio associated with the treatment.  Basically, the higher the risk, the worse the symptoms usually have to be before the surgeon and patient are willing to perform the surgery. As technology has advanced, the risk associated with many procedures has generally decreased, subsequently leading to surgeons and patients opting to perform the procedure…

14 February 2018Modern LFR. Does the data stack up?

Author: Dr. Paul I. Singh, MD

In recent years, there has no doubt been an increased interest in modern laser floater removal, LFR. Within the past five years since I began performing the procedure, more and more surgeons are now adopting LFR in their practices. Although the procedure may seem fairly new, surgeons may not realize that the use of a YAG laser to treat symptomatic floaters has been performed for many decades. So, why is this procedure only now starting to gain traction?   Previous…

21 December 2017LFR: Can the Vitreous Help Explain the Unhappy Postop Cataract Patient?

Author: Dr. Paul I. Singh

“Can the Vitreous Help Explain the Unhappy Postop Cataract Patient?”   Our cataract patients’ expectations have steadily increased as our surgical technique and IOL technology has advanced over the years.  As a profession, we have focused a great deal of attention on the smallest detail during the entire process; pre-op, (including biometry, topography, OCT), to intraoperative tools and techniques (such as femtosecond assisted surgery, intra op aberrometry, and premium IOLs), to postop drop and capsule management.  This increased attention-to-detail has…

1 August 2017LFR: Does Technology Define When a Condition is Worth Treating?

Author: Dr. Paul I. Singh

“Does Technology Define When a Condition is Worth Treating?” Historically, as a profession, we have created the perception that vitreous floaters (opacities) are a mere annoyance to our patients.  A condition that, although many people complain of, does not cause a significant enough impact on quality of life and daily functioning to warrant treatment. Why is that? Why is it considered just an annoyance when patients often complain of difficulty driving, reading, or even working on a computer? Is it…